t-lymphocytes

Documents about t-lymphocytes

• Double-negative αβ T lymphocytes: What are the etiological considerations?#475962HAL (France)
• T-lymphocyte populations following a period of high volume training in female soccer players#648578STORRE
• Rôle du microenvironnement tumoral dans l'expansion des lymphomes B#238992HAL (France)
• Orchestration de la réponse cytotoxique des lymphocytes T CD4+ par SLAMF4 au cours de la polyarthrite rhumatoïde#670041HAL (France)
• Human respiratory syncytial virus infects and induces activation markers in mouse B lymphocytes#646710Repisalud
• Administration of Virus-Specific Cytotoxic T-Lymphocytes#841304ClinicalTrials.gov
• Importance et potentiel thérapeutique d'un nouveau couple récepteur-ligand dans l'inhibition des lymphocytes T CD8 par les lymphocytes T régulateurs dans les tumeurs#301074HAL (France)
• Immunomodulation During Pregnancy#845344ClinicalTrials.gov
• Acquisition of new migratory properties by highly differentiated cd4+cd28null t lymphocytes in rheumatoid arthritis disease#935707Repositorio de Universidad Autónoma de Chile.
• Modulations quantitatives et qualitatives de l'activation des lymphocytes T humains par la kinase LCK et les récepteurs de costimulation#226827HAL (France)
• Study Evaluating Ovasave, an Autologous Cell Therapy, in Patients With Active Crohn's Disease#858285ClinicalTrials.gov
• Monitoring Concentration and Pharmacodynamic Effects of Tacrolimus in Peripheral Blood Lymphocytes of Kidney Transplant Recipients#1007494ClinicalTrials.gov
• Characterization of CD8 T cell immune responses directed against cytomegalovirus in people living with human immunodeficiency virus (HIV)#142647HAL (France)
• TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer#904606ClinicalTrials.gov
• The Effectiveness of Mangosteen Peels Extract Against The Total of T Lymphocytes in HIV Patients#1004759Jurnal Ners
• Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes#162454ClinicalTrials.gov
• Urinary T Cell Biomarker for Prediction in Lupus Nephritis#876974ClinicalTrials.gov
• Effect of Activated T Lymphocytes on the Regulation of Hematopoiesis#70487J-STAGE (Japan)
• Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)#903028ClinicalTrials.gov
• Rôle de la protéine autophagique LC3B au cours de l'étape d'entrée du VIH-1 dans les lymphocytes T CD4+#226784HAL (France)
• Surface expression of functional T cell receptor chains formed by interlocus recombination on human T lymphocytes.#284153HAL (France)
• Invalidation des immune checkpoints PD-1 et TIGIT dans des lymphocytes T CD8+ spécifiques de tumeur : conséquences fonctionnelles et utilisation en immunothérapie#268566HAL (France)
• Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes#377407ClinicalTrials.gov
• Immunopathology of Loeys-Dietz Syndrome#884789ClinicalTrials.gov
• Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy#126895HAL (France)
• Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients with Synovial Sarcoma#195305ClinicalTrials.gov
• BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes#644884Lund University Publications
• In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies#800465ClinicalTrials.gov
• ALVAC-HIV vCP1452 Alone and Combined With MN rgp120#853256ClinicalTrials.gov
• REGulatory T Cells in Autism Induced by Maternal Immune Activation#993013ClinicalTrials.gov
• T Regulatory Lymphocytes (Treg) Depletion for Cancer Treatment Efficacy and Safety Study#633717ClinicalTrials.gov
• Production de lymphocytes T à Récepteur d'Antigène Chimérique pour améliorer l’immunothérapie anti-tumorale#213132HAL (France)
• Decreased CD3+CD56+ Natural Killer T Lymphocytes and Increased Human Leukocyte Antigen-DR+ Cells in the Inflamed Area of Pouchitis in Ulcerative Colitis Patients#455581OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Lymphocytes T régulateurs induits par Faecalibacterium prausnitzii : modalités de leur induction et signification fonctionnelle#475986HAL (France)
• STAT3 and STAT5B Mutations in T/NK-Cell Chronic Lymphoproliferative Disorders of Large Granular Lymphocytes (LGL): Association with Disease Features#291393Gestión del Repositorio Documental de la Universidad de Salamanca
• Immunohistochemical evaluation of the cellular immune response to Rickettsia conorii in taches noires#291410Gestión del Repositorio Documental de la Universidad de Salamanca
• Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer#895516ClinicalTrials.gov
• Expression of the Inhibitory Receptors on Lymphocytes T Cells After Lung Cancer Surgery.#994077ClinicalTrials.gov
• T lymphocyte subsets in Mediterranean spotted fever#291415Gestión del Repositorio Documental de la Universidad de Salamanca
• Study of Donor Derived, Multi-virus-specific, Cytotoxic T-Lymphocytes for Relapsed/Refractory Neuroblastoma#226241ClinicalTrials.gov
• HIV-1 infection does not confer intrinsic resistance to cell death induced by cytotoxic T lymphocytes#238018bioRxiv / medRxiv
• Foundation and Clinical About the Expression of PD-1 in Peripheral Blood T Lymphocytes#238131ClinicalTrials.gov
• Reconstitution of CD4+CD25highCD127low/-Tcell#849242ClinicalTrials.gov
• IL-2 and IL-15 drive intrathymic development of distinct periphery-seeding CD4+Foxp3+ regulatory T lymphocytes#178295Ora Oxford University Research
• TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC#353283ClinicalTrials.gov
• Study of Phenotypic and Functional Characteristics of Regulatory T Lymphocytes in Horton's Disease#830762ClinicalTrials.gov
• Effect of Severe Trauma on PD1 and Its Legend (PD1/L1) on T Lymphocytes and Correlation With Mortality#861260ClinicalTrials.gov
• Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?#235408IRIS
• Rôle de l'inflammation et du facteur de transcription Foxo1 dans l'exhaustion des cellules T au cours des réponses anti-tumorales#326245HAL (France)
• Réponses lymphocytaires T CD8 et CD4 spécifiques de l'antigène dans les cancers épithéliaux induits par le papillomavirus humain (HPV)#280379HAL (France)